148561 Emergency Contraception and Women's Health: From Policy and Politics to Practice

Monday, November 5, 2007

Alice Richman, MPH, BA , College of Public Health, Community and Family Health, University of South Florida, Boynton Beach, FL
Emergency contraception (EC) is a safe and effective form of contraception that is 75%-89% effective in preventing pregnancies within 120 hours of unprotected intercourse. Wider access to EC has the potential to decrease the number of unintended pregnancies and abortions in the U.S.

The Food and Drug Administration (FDA) has previously denied any over-the-counter (OTC) access to EC and only recently approved it for OTC status for women 18 years old and over; therefore, pharmacists continue to play a critical role in providing access to EC. Pharmacists can answer women's questions, dispel misconceptions, and provide important information about the medication to clients. Although EC is a safe medication, many pharmacists, pharmacies, and other healthcare professionals have either refused to dispense EC or have refused to carry and stock EC which all have major implications for public health and access to care for women, children, and families.

EC policy has come a long way since 1960s when packets of birth control pills were cut up to dispense the required dose to women at feminist, college health, and Planned Parenthood clinics. The history of EC policy and politics has been wrought with road blocks based on moral declarations and has lacked sound scientific evidence. Although the new legislation is a positive step for women's health and women's rights, it is not enough. This presentation will provide the learner with an understanding of EC history, policy, and politics, and will assess how current policy and refusals by healthcare professionals may impact women's health.

Learning Objectives:
1. Understand the history of policy and politics related to emergency contraception. 2. Discuss the new emergency contraception policy promulgated by the Food and Drug Administration and understand how this policy may strengthen or weaken women’s health and women’s rights. 3. Assess pharmacists’ and other healthcare professionals' refusals to dispense emergency contraception in the U.S. and articulate how these refusals may impact women’s rights, health, and access to care.

Keywords: Women's Health, Contraception

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.